|
US2010267672A1
|
|
Novel compounds of reverse-turn mimetics, method for manufacturing the same and use thereof
|
|
WO2010027114A1
|
|
Use of pyrazole-pyridine derivatives and its salts for treating or reventin osteoporosis
|
|
US7671054B1
|
|
Reverse-turn mimetics and method relating thereto
|
|
WO2008007836A1
|
|
Method for preparing 4-acetoxyazetidinone and derivatives thereof
|
|
AT509135A1
|
|
Process for preparing optically active cyclopropancarboxamide and derivatives thereof
|
|
WO2006126825A1
|
|
Composition comprising tetrafluorobenzyl derivatives or salts of thereof for injection
|
|
US7563825B1
|
|
Modulation of beta-catenin coactivator interactions to effect stem cell growth or differentiation
|
|
US2007043052A1
|
|
Reverse-turn mimetics and method relating thereto
|
|
BRPI0413969A
|
|
transcription modulation activated by -catenin / tcf
|
|
US2007021425A1
|
|
Reverse-turn mimetics and method relating thereto
|
|
US2007021431A1
|
|
Reverse-turn mimetics and method relating thereto
|
|
CN101805340A
|
|
Beta-chain simulative and methods involving thereof
|
|
US2004053331A1
|
|
Beta-strand mimetics and method relating thereto
|
|
AU2003249672A1
|
|
Beta-strand mimetics and method relating thereto
|
|
US2004072831A1
|
|
Reverse-turn mimetics and method relating thereto
|
|
CN1585770A
|
|
Reverse-turn mimetics and method relating thereto
|
|
CN1872857A
|
|
Reverse-turn mimetics and method relating thereto
|
|
US6762185B1
|
|
Compounds useful for treatment of cancer, compositions containing the same, and methods of their use
|
|
EP1039909A1
|
|
Method of production and composition of an oral preparation of itraconazole
|
|
WO9923090A1
|
|
Novel genipin derivative having liver protection activity
|
